{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:37:08Z","timestamp":1790768228333,"version":"4.1.0"},"reference-count":25,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T00:00:00Z","timestamp":1447372800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0142923","type":"journal-article","created":{"date-parts":[[2015,11,13]],"date-time":"2015-11-13T14:00:27Z","timestamp":1447423227000},"page":"e0142923","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":44,"title":["Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study"],"prefix":"10.1371","volume":"10","author":[{"given":"Gisela","family":"Leierer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Grabmeier-Pfistershammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Steuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Geit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Sarcletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Kanatschnig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Rappold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zangerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Ledergerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninon","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Austrian HIV Cohort Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,11,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","year":"2008","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"FJ Palella Jr.","year":"1998","journal-title":"N Engl J Med"},{"key":"ref3","unstructured":"Panel on Antiretroviral Guidelines for adults and adolescents for the use of ART in HIV -1 infecrted Adults and Adolescents. Department of Health and Human Services. Available at <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/aidsinfo.nih.gov\/guidelines\" xlink:type=\"simple\">http:\/\/aidsinfo.nih.gov\/guidelines<\/ext-link>. Accessed 26th August 2015."},{"key":"ref4","article-title":"European AIDS Clinical Society version 7.1","year":"2014"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/jac\/dkt484","article-title":"Markers associated with persisting low-level viraemia under antiretroviral therapy in HIV-1 infection","volume":"69","author":"L Vancoillie","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1371\/journal.ppat.0030046","article-title":"ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia","volume":"3","author":"F Maldarelli","year":"2007","journal-title":"PLoS Pathog"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/01.aids.0000188426.87538.ed","article-title":"Residual viraemia in subjects with chronic HIV infection and viral load &lt; 50 copies\/ml: the impact of highly active antiretroviral therapy","volume":"19","author":"L Palmisano","year":"2005","journal-title":"Aids"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/j.1468-1293.2012.01012.x","article-title":"Factors associated with a strictly undetectable viral load in HIV-1-infected patients","volume":"13","author":"G Martin-Blondel","year":"2012","journal-title":"HIV Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/QAI.0b013e3182099891","article-title":"Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep\/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays","volume":"56","author":"JM Sire","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.3851\/IMP1427","article-title":"Initial evaluation of the Roche COBAS TaqMan HIV-1 v2.0 assay for determining viral load in HIV-infected individuals","volume":"14","author":"N Taylor","year":"2009","journal-title":"Antivir Ther"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1128\/JCM.00288-14","article-title":"Ability of two commercially available assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep\/Cobas TaqMan HIV-1 Version 2.0) to quantify low HIV-1 RNA Levels (&lt;1,000 copies\/milliliter): comparison with clinical samples and NIBSC working reagent for nucleic acid testing assays","volume":"52","author":"A Amendola","year":"2014","journal-title":"J Clin Microbiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00430-012-0249-y","article-title":"Comparison of HIV-1 viral load assay performance in immunological stable patients with low or undetectable viremia","volume":"202","author":"G Naeth","year":"2013","journal-title":"Med Microbiol Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e74024","DOI":"10.1371\/journal.pone.0074024","article-title":"Cobas ampliprep\/cobas TaqMan HIV-1 v2.0 assay: consequences at the cohort level","volume":"8","author":"N Taylor","year":"2013","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1128\/JCM.02461-13","article-title":"Comparative performances of HIV-1 RNA load assays at low viral load levels: results of an international collaboration","volume":"52","author":"LC Swenson","year":"2014","journal-title":"J Clin Microbiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/cid\/cir936","article-title":"Plasma HIV-1 RNA detection below 50 copies\/ml and risk of virologic rebound in patients receiving highly active antiretroviral therapy","volume":"54","author":"T Doyle","year":"2012","journal-title":"Clin Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1473-3099(13)70093-8","article-title":"Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials","volume":"13","author":"JJ Eron","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/cid\/cit529","article-title":"Virologic failure following persistent low-level viremia in a cohort of HIV-positive patients: results from 12 years of observation","volume":"57","author":"C Laprise","year":"2013","journal-title":"Clin Infect Dis"},{"key":"ref18","unstructured":"Ribaudo H Lennox J, Currier J (2009) Virological failure endpoint definition in clinical trials: Is using HIV-1RNA threshold &lt;200 copies\/mL better than 50 copies\/mL? An analysis of the ACTG studies. Paper presented at: Conference on Retroviruses and Opportunistic Infections; Montreal, Canada."},{"key":"ref19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/infdis\/jir353","article-title":"Antiretroviral drug resistance in HIV-1-infected patients experiencing persistent low-level viremia during first-line therapy","volume":"204","author":"B Taiwo","year":"2011","journal-title":"J Infect Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbrc.2009.05.148","article-title":"Lopinavir co-induces insulin resistance and ER stress in human adipocytes","volume":"386","author":"M Djedaini","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1086\/595707","article-title":"Detection of HIV type 1 load by the Roche Cobas TaqMan assay in patients with viral loads previously undetectable by the Roche Cobas Amplicor Monitor","volume":"48","author":"H Gatanaga","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jcv.2005.08.008","article-title":"Increased levels of HIV RNA detected in samples with viral loads close to the detection limit collected in Plasma Preparation Tubes (PPT)","volume":"35","author":"BP Griffith","year":"2006","journal-title":"J Clin Virol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/QAI.0b013e31819e721b","article-title":"Increased reporting of detectable plasma HIV-1 RNA levels at the critical threshold of 50 copies per milliliter with the Taqman assay in comparison to the Amplicor assay","volume":"51","author":"V Lima","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/j.1468-1293.2012.01016.x","article-title":"Apparent low-level HIV RNA viraemia related to sample processing time","volume":"13","author":"MD Portman","year":"2012","journal-title":"HIV Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1471-2334-12-100","article-title":"HIV-1 low-level viraemia assessed with 3 commercial real-time PCR assays show high variability","volume":"12","author":"J Ruelle","year":"2012","journal-title":"BMC Infect Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0142923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T08:44:12Z","timestamp":1718181852000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0142923"}},"subtitle":[],"editor":[{"given":"Paul Richard","family":"Harrigan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,11,13]]},"references-count":25,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2015,11,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0142923","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,13]]}}}